<code id='917E7F2860'></code><style id='917E7F2860'></style>
    • <acronym id='917E7F2860'></acronym>
      <center id='917E7F2860'><center id='917E7F2860'><tfoot id='917E7F2860'></tfoot></center><abbr id='917E7F2860'><dir id='917E7F2860'><tfoot id='917E7F2860'></tfoot><noframes id='917E7F2860'>

    • <optgroup id='917E7F2860'><strike id='917E7F2860'><sup id='917E7F2860'></sup></strike><code id='917E7F2860'></code></optgroup>
        1. <b id='917E7F2860'><label id='917E7F2860'><select id='917E7F2860'><dt id='917E7F2860'><span id='917E7F2860'></span></dt></select></label></b><u id='917E7F2860'></u>
          <i id='917E7F2860'><strike id='917E7F2860'><tt id='917E7F2860'><pre id='917E7F2860'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:92666
          Light at the end of a hospital corridor, where an empty gurney parked — health tech coverage from STAT
          Adobe

          Health professor Neil Wenger was deep into a years-long study on seriously ill primary care patients when he uncovered a different but persistent issue: Many patients who were targeted for follow-up interventions had actually died, and their hospitals did not know about it.

          It wasn’t what Wenger had set out to research. But it was unacceptable, he said, for health systems to lose track of seriously ill primary care patients who’d been treated on-site for years. To be clear, these were not one-time out-of-state patients who’d come in for a single visit.

          advertisement

          “When I found a bunch of them were dead and we didn’t actually know it, that’s when I said we need to describe it,” he said. “This is a cohort where we need to know about everyone who is dead.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          The struggle to figure out which patients 'deserve' Wegovy
          The struggle to figure out which patients 'deserve' Wegovy

          AdobeThereisjustnotenoughWegovy.Thecurrentmanufacturingshortagewilleventuallyend,andthosewhohaveheal

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo